Search - tctmd.com

Displaying 321 - 340 of 386

Sort: Relevancy | Date

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

Presentation TVT 2015

Thoughtful Commentary: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Fabian Nietlispach

June 04, 2015

Presentation TVT 2015

Case Presentation: LAA Occlusion and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Brij Maini

June 04, 2015

News Daily News

Study Documents Complications of LAA Closure With the Lariat Device

May 05, 2015

News Daily News

大规模登记研究表明 Amplatzer 封堵器能够减少房颤患者的卒中和出血风险

Todd Neale

February 17, 2015

News Daily News

Un Amplio Estudio de Registro Sugiere que el Enchufe Amplatzer Reduce los Riesgos Hemorrágico y de ACV en el Manejo de la FA

Todd Neale

February 17, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Todd Neale

February 17, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

News Daily News

Registry Data Suggest Protection Up to 2 Years With LAA Closure

Caitlin E. Cox

January 28, 2015

News Daily News

对房颤患者使用Amplatzer进行LAA封堵显得安全、有效

Yael L. Maxwell

November 06, 2014

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Yael L. Maxwell

November 06, 2014

Presentation

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Presenter: G. Santoro

November 05, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

Presentation TCT 2014

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

Presenter: Josep Rodés-Cabau, Peter B Sick, Krzysztof Bartus, Dongming Hou

September 16, 2014

Presentation TCT 2014

LAA Occlusion Devices Stuck in the Mud Matching the Right Patients with the Best Trial Designs (and Endpoints)

Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Matthew J. Price, Brian K. Whisenant

September 16, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

Opportunities for and Challenges of Current and Future LAA Occlusion Technologies

Presenter: Mark Reisman

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Advertisement

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Thoughtful Commentary: LAA Occlusion and TAVR

Case Presentation: LAA Occlusion and TAVR

Study Documents Complications of LAA Closure With the Lariat Device

大规模登记研究表明 Amplatzer 封堵器能够减少房颤患者的卒中和出血风险

Un Amplio Estudio de Registro Sugiere que el Enchufe Amplatzer Reduce los Riesgos Hemorrágico y de ACV en el Manejo de la FA

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

LAA Occlusion for Stroke Prevention in A-Fib

Registry Data Suggest Protection Up to 2 Years With LAA Closure

对房颤患者使用Amplatzer进行LAA封堵显得安全、有效

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

El Cierre del AAI con Amplatzer parece Seguro y Eficaz en Pacientes con FA

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

TCT 175: Preclinical Study of the Novel Generation of Watchman for Left Atrial Appendage Occlusion

LAA Occlusion Devices Stuck in the Mud Matching the Right Patients with the Best Trial Designs (and Endpoints)

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

Opportunities for and Challenges of Current and Future LAA Occlusion Technologies

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content